Serious infections in patients with rheumatoid arthritis

被引：0
|
作者：
Maerker-Hermann, E. [1 ]
Nitschmann, S. [1 ]
机构：
[1] HELIOS Dr Horst Schmidt Kliniken Wiesbaden, Klin Immunol & Nephrol, Klin Innere Med 4, Rheumatol, Ludwig Erhard Str 100, D-65199 Wiesbaden, Germany
来源：
INTERNIST | 2016年 / 57卷 / 03期
关键词：
D O I：
10.1007/s00108-015-0012-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：298 / 300
页数：3
相关论文
共 50 条
  • [21] PREDICTORS OF SERIOUS INFECTIONS IN RHEUMATOID ARTHRITIS - A LONGITUDINAL BRAZILIAN COHORT
    De Almeida, Ana Luisa Bagno
    Guimaraes, Maria Fernanda B. Resende
    da Mota, Licia Maria Henrique
    Castelar-Pinheiro, Geraldo da Rocha
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S76 - S77
  • [22] Serious infections in rheumatoid arthritis: Relationship to immunosuppressive use.
    Singh, G
    Ramey, DR
    Rausch, PL
    Schettler, JD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S242 - S242
  • [23] PREDICTORS OF SERIOUS INFECTIONS IN RHEUMATOID ARTHRITIS - A PROSPECTIVE BRAZILIAN COHORT
    de Almeida, A. L. Bagno
    Guimaraes, M. F.
    Da Costa Pinto, M. Raquel
    Pereira, L.
    Gomides, A. P.
    Bonfiglioli, K.
    Louzada, P., Jr.
    Giorgi, R.
    Castro, G.
    Radominski, S.
    Brenol, C.
    Pugliesi, A.
    Mota, L.
    Castelar Pinheiro, G. Da Rocha
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 530 - 531
  • [24] Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan
    Toshihiro Nanki
    Tomohiro Yamaguchi
    Kosei Umetsu
    Ryunosuke Tanabe
    Naoki Maeda
    Minori Kanazawa
    Yuko Furuno
    Shinichi Matsuda
    Shinya Takemoto
    Keiko Asao
    Tatsuya Kamiuchi
    Clinical Rheumatology, 2025, 44 (3) : 1081 - 1093
  • [25] The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
    Curtis, Jeffrey R.
    Xie, Fenglong
    Chen, Lang
    Baddley, John W.
    Beukelman, Timothy
    Saag, Kenneth G.
    Spettell, Claire
    McMahan, Raechele M.
    Fernandes, Joaquim
    Winthrop, Kevin
    Delzell, Elizabeth
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08) : 1401 - 1406
  • [26] Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib
    Hetland, Merete Lund
    Strangfeld, Anja
    Bonfanti, Gianluca
    Soudis, Dimitrios
    Deuring, J. Jasper
    Edwards, Roger A.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [27] Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections
    Gron, Kathrine Lederballe
    Arkema, Elizabeth V.
    Glintborg, Bente
    Mehnert, Frank
    Ostergaard, Mikkel
    Dreyer, Lene
    Norgaard, Mette
    Krogh, Niels Steen
    Askling, Johan
    Hetland, Merete Lund
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] Rates of serious infections from adalimumab (HUMIRA®) clinical trials of patients with Rheumatoid Arthritis (RA)
    Kent, J. D.
    Pangan, A. L.
    Spencer-Green, G. T.
    Szczerbak, N.
    Sasso, E. H.
    RHEUMATOLOGY, 2006, 45 : I42 - I43
  • [29] RISK OF SERIOUS INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT, RITUXIMAB AND TOCILIZUMAB IN DENMARK AND SWEDEN
    Gron, K. L.
    Arkema, E.
    Glintborg, B.
    Mehnert, F.
    Ostergaard, M.
    Dreyer, L.
    Norgaard, M.
    Krogh, N. S.
    Askling, J.
    Heltand, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 208 - 208
  • [30] Serious infections in patients with rheumatoid arthritis who participated in adalimumab (HUMIRA®) clinical trials.
    Kent, J
    Pangan, A
    Spencer-Green, G
    Szczerbak, N
    Sasso, E
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S548 - S548
12345